Cargando…

Cushing Disease with Glucocorticoid-induced Positive Feedback—A New Subtype of Pituitary Corticotropinomas?

Detalles Bibliográficos
Autor principal:	Tóth, Miklós
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143653/ https://www.ncbi.nlm.nih.gov/pubmed/34061123 http://dx.doi.org/10.1210/jendso/bvab079

Ejemplares similares

USP8 Somatic Mutations in Cushing’s Disease and Silent Corticotropinomas
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets
por: Ciato, Denis, et al.
Publicado: (2020)

Corticotropinoma as a Component of Carney Complex
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2017)

Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
por: Tsujimoto, Yasutaka, et al.
Publicado: (2021)

MON-905 A Case of Cushing’s Disease with Glucocorticoid Positive-Feedback
por: Shichi, Hiroki, et al.
Publicado: (2020)

Demystifying the Relevance of Size Amongst Macro- and Micro-Corticotropinoma: Experience in 206 Patients
por: Gupta, Rahul, et al.
Publicado: (2022)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Genomics in Cushing’s Disease: The Dawn of a New Era
por: Reincke, Martin, et al.
Publicado: (2021)

Pituitary oncocytoma presenting as Cushing's disease
por: Garg, M.K., et al.
Publicado: (2013)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations
por: Daniel, Eleni, et al.
Publicado: (2017)

Pituitary tumor centers of excellence for Cushing’s disease
por: Couselo, Marcos, et al.
Publicado: (2022)

Double Pituitary Adenomas in Patients With Cushing’s Disease
por: Voznyak, Oleksandr, et al.
Publicado: (2023)

Progression of an Invasive ACTH Pituitary Macroadenoma with Cushing's Disease to Pituitary Carcinoma
por: Borba, Clarissa Groberio, et al.
Publicado: (2015)

Disseminated Cryptococcosis in a Patient with Pituitary Cushing’s Disease
por: Kang, Cheol-In, et al.
Publicado: (2003)

Pediatric Cushing's Disease and Pituitary Incidentaloma: Is This a Real Challenge?
por: Paragliola, Rosa Maria, et al.
Publicado: (2014)

Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020)

Glucocorticoid‐induced hyperglycaemia and diabetes: Call for action
por: Golubic, Rajna, et al.
Publicado: (2022)

Canine Pituitary Organoids as 3D In Vitro Model for Cushing Disease
por: Sanders, Karin, et al.
Publicado: (2021)

SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020)

SAT-248 Cushing’s Disease with Two ACTH-Producing Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020)

Pituitary adenomas evade apoptosis via noxa deregulation in Cushing’s disease
por: Asuzu, David T., et al.
Publicado: (2022)

Severe Hypercortisolism with Hypokalemic Alkalosis Mimicking Ectopic Cushing Syndrome in a Patient with Cushing Disease Due to Pituitary Microadenoma
por: Goyal, Alpesh, et al.
Publicado: (2018)

Harvey Cushing and the Secretion of the Posterior Pituitary into the C.S.F.
por: Aziz, T Z
Publicado: (1988)

Clival Ectopic Pituitary Adenoma Causing Cushing Syndrome
por: Karthik, Subramaniam, et al.
Publicado: (2023)

Radiation-induced Undifferentiated Malignant Pituitary Tumor After 5 Years of Treatment for Cushing Disease
por: Bakshi, Gazal, et al.
Publicado: (2023)

COVID-19 and Cushing’s disease in a patient with ACTH-secreting pituitary carcinoma
por: de Filette, J M K, et al.
Publicado: (2022)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
por: He, Xin, et al.
Publicado: (2022)

MON-405 Cushing's Disease: An Oligosymptomatic Patient with ACTH-Secreting Pituitary Macroadenoma
por: Manrique Franco, Katty, et al.
Publicado: (2019)

Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case
por: Armstrong, Stephanie A, et al.
Publicado: (2023)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

Autoregulation of Sec7 Arf-GEF activity and localization by positive feedback
por: Richardson, Brian C., et al.
Publicado: (2012)

Glucocorticoids and “Stress” Are Not Synonymous
por: MacDougall-Shackleton, S A, et al.
Publicado: (2019)

Salivary Cortisol in the Diagnosis of Cushing Syndrome, Always More Than One!
por: Fleseriu, Maria
Publicado: (2020)

Cushing’s syndrome with no clinical stigmata – a variant of glucocorticoid resistance syndrome
por: Gossain, Ved V., et al.
Publicado: (2018)

Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
por: Curtò, Lorenzo, et al.
Publicado: (2010)

Thyrotoxicosis in a 13‐year‐old girl following pituitary adenectomy for Cushing′s disease
por: Sigmarsdottir, Arndis Audur, et al.
Publicado: (2017)

Glucocorticoids and breast cancer risk
por: Hirko, Kelly A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u8vauft317ejmkkhmg9qc7d0nc